Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$643M |
| 2 |
AT&T
T
|
+$311M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$306M |
| 4 |
Microsoft
MSFT
|
+$292M |
| 5 |
Ametek
AME
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$887M |
| 2 |
Apple
AAPL
|
+$694M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$616M |
| 4 |
Amazon
AMZN
|
+$596M |
| 5 |
Linde
LIN
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 58.05% |
| 2 | Technology | 7.69% |
| 3 | Financials | 6.83% |
| 4 | Healthcare | 6.42% |
| 5 | Industrials | 4.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3501
Gyre Therapeutics
GYRE
$699M
| $2.76M | ﹤0.01% |
89,497
-15,536
| -15% | -$511K |
|
|
NUAN
3502
CALL
DELISTED
Nuance Communications, Inc.
NUAN
| $2.76M | ﹤0.01% |
50,100
-44,200
| -47% | -$2.43M |
|
3503
Ball Corp
BALL
$16.9B
| $2.76M | ﹤0.01% |
30,629
-537,100
| -95% | -$47.6M |
|
3504
Healthpeak Properties
DOC
$14.5B
| $2.75M | ﹤0.01% |
82,250
+10,363
| +14% | +$367K |
|
3505
Sensata Technologies
ST
$5.97B
| $2.75M | ﹤0.01% |
50,284
-154,007
| -75% | -$8.85M |
|
3506
Enpro
NPO
$6.33B
| $2.75M | ﹤0.01% |
31,555
-11,124
| -26% | -$977K |
|
|
TRTX
3507
TPG RE Finance Trust
TRTX
$593M
| $2.75M | ﹤0.01% |
221,925
-62,009
| -22% | -$794K |
|
|
AMRS
3508
CALL
DELISTED
Amyris Inc.
AMRS
| $2.75M | ﹤0.01% |
+200,000
| New | +$2.86M |
|
3509
Shattuck Labs
STTK
$707M
| $2.74M | ﹤0.01% |
+134,532
| New | +$2.88M |
|
3510
Arbor Realty Trust
ABR
$944M
| $2.74M | ﹤0.01% |
147,874
-200,467
| -58% | -$3.62M |
|
3511
PUT
GameStop
GME
$8.02B
| $2.74M | ﹤0.01% |
62,400
-138,800
| -69% | -$6.34M |
|
|
KRTX
3512
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $2.73M | ﹤0.01% |
+22,348
| New | +$2.58M |
|
|
KNTE
3513
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $2.73M | ﹤0.01% |
+118,734
| New | +$2.58M |
|
3514
CALL
Vornado Realty Trust
VNO
$7.13B
| $2.73M | ﹤0.01% |
+65,000
| New | +$2.8M |
|
3515
Lloyds Banking Group
LYG
$85.7B
| $2.73M | ﹤0.01% |
1,113,838
-2,333,536
| -68% | -$5.72M |
|
|
FZT
3516
DELISTED
FAST Acquisition Corp. II
FZT
| $2.73M | ﹤0.01% |
280,999
-331,048
| -54% | -$3.22M |
|
|
HT
3517
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
| $2.72M | ﹤0.01% |
291,976
+187,291
| +179% | +$1.78M |
|
|
KIII
3518
DELISTED
Kismet Acquisition Three Corp. Class A Ordinary Shares
KIII
| $2.72M | ﹤0.01% |
279,934
+95,744
| +52% | +$925K |
|
|
XHR
3519
Xenia Hotels & Resorts
XHR
$1.8B
| $2.72M | ﹤0.01% |
153,516
-105,586
| -41% | -$1.85M |
|
3520
PUT
KE Holdings
BEKE
$20.2B
| $2.72M | ﹤0.01% |
149,000
-7,400
| -5% | -$180K |
|
3521
Pharvaris
PHVS
$2.48B
| $2.72M | ﹤0.01% |
157,753
-39,214
| -20% | -$671K |
|
|
FTH
3522
Faeth Therapeutics
FTH
$874M
| $2.72M | ﹤0.01% |
+12,933
| New | +$2.35M |
|
|
GCAC
3523
DELISTED
Growth Capital Acquisition Corp. Class A Common Stock
GCAC
| $2.72M | ﹤0.01% |
275,366
+238,652
| +650% | +$2.35M |
|
3524
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
$19.8B
| $2.72M | ﹤0.01% |
51,724
-7,678
| -13% | -$403K |
|
|
VEEA
3525
Veea Inc
VEEA
$6.41M
| $2.72M | ﹤0.01% |
281,094
-46,338
| -14% | -$451K |
|
Similar funds
Israel Englander's Q3 2021 Portfolio in Review
As of Q3 2021, Israel Englander held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Israel Englander's Q3 2021 filing shows 1,245 new, 2,719 increased, 2,446 reduced and 981 closed positions. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M. The largest sale was Alexion Pharmaceuticals, an estimated $887M.
By sector, the portfolio is most concentrated in Miscellaneous at 58% of assets, up from 55% a quarter earlier, followed by Technology and Financials.
- Israel Englander's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
- Israel Englander's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
- Israel Englander fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
- Israel Englander's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
- Israel Englander opened 1,245 new positions and closed 981 in Q3 2021.
- Israel Englander's portfolio value rose 2.3% quarter-over-quarter to $167B.
Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.